Hemichorea as the First and Sole Manifestation in Lupus: Case-Based Review

Considering her age, raised ESR and prolonged APTT, SLE with anti-phospholipid antibody syndrome was strongly suspected and further evaluation revealed positive anti-nuclear antibody (ANA) by indirect immunofluorescence (IF)- 3+ nuclear homogenous pattern in 1:100 dilution, raised anti-double strand...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mediterranean Journal of Rheumatology 2024-03, Vol.35 (1), p.156-163
Hauptverfasser: Gangadharan, Harikrishnan, Peter, Rahul, Vs, Vineetha, Punnoose, Varghese, George, Josemon
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 163
container_issue 1
container_start_page 156
container_title Mediterranean Journal of Rheumatology
container_volume 35
creator Gangadharan, Harikrishnan
Peter, Rahul
Vs, Vineetha
Punnoose, Varghese
George, Josemon
description Considering her age, raised ESR and prolonged APTT, SLE with anti-phospholipid antibody syndrome was strongly suspected and further evaluation revealed positive anti-nuclear antibody (ANA) by indirect immunofluorescence (IF)- 3+ nuclear homogenous pattern in 1:100 dilution, raised anti-double stranded DNA (Anti dsDNA)- 125 IU/ml (0-25 IU/ml), low C3- 47mg/dl (90-180mg/dl), low C4- 3.07mg/dl (10-40mg/dl) and positive lupus anticoagulant 1.94 (0-1.3). Magnetic resonance imaging (MRI) Brain was normal and Digital subtraction angiography (DSA) did not show any evidence of CNS vasculitis. [...]a final diagnosis of SLE with neuropsychiatric lupus in the form of left hemichorea and secondary antiphospholipid antibody syndrome was made. The American College of Rheumatology (ACR) nomenclature for neuropsychiatry syndromes in SLE includes 12 central nervous system syndromes and 7 peripheral nervous system syndromes.2 The classification of pathogenic mechanisms responsible for various neuropsychiatry syndromes into ischemic and neuroinflammatory may be an oversimplification of this clinically challenging entity. In prior case reports where chorea has been the presenting feature of SLE, the onset of other clinical features of SLE has varied from being present during the initial evaluation of chorea to a few weeks after the onset of chorea.9-13 The exact pathogenesis of chorea in SLE may be multifactorial involving 1) ischemia of small and large vessels in CNS mediated by anti-phospholipid antibodies and immune complexes, and 2) inflammatory neuronal injury secondary to complement activation, inflammatory cytokines, and increased permeability of blood-brain barrier causing autoantibodies to migrate to the intrathecal space.
doi_str_mv 10.31138/mjr.180323.haf
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3054434489</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3054434489</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2712-94c4d99ce312a4044827102d9d7fedb5c77affe98795ed93ac714b37487b67f73</originalsourceid><addsrcrecordid>eNpdkE1LAzEQhoMottSevUnAi5dt87VN4k2LtUpF8AO8LdnNhG7p7tZkV_HfG20V8TIzDM-8DA9Cx5SMOKVcjauVH1FFOOOjpXF7qM9SphOq1cv-n7mHhiGsCCGMSqJVeoh6XEk-0anoo9s5VGWxbDwYbAJul4BnpQ8tNrXFj80a8J2pSwehNW3Z1Lis8aLbdOEcT02A5DIWix_grYT3I3TgzDrAcNcH6Hl29TSdJ4v765vpxSIpmKQs0aIQVusCOGVGECFUXBNmtZUObJ4WUhrnQCupU7Cam0JSkXMplMwn0kk-QGfb3I1vXrv4WVaVoYD12tTQdCHjJBWCx1wd0dN_6KrpfB2_y74MpppFS5Eab6nCNyF4cNnGl5XxHxkl35zKoulsazqLpuPFyS63yyuwv_yPV_4JV2J4Rg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3113592252</pqid></control><display><type>article</type><title>Hemichorea as the First and Sole Manifestation in Lupus: Case-Based Review</title><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Gangadharan, Harikrishnan ; Peter, Rahul ; Vs, Vineetha ; Punnoose, Varghese ; George, Josemon</creator><creatorcontrib>Gangadharan, Harikrishnan ; Peter, Rahul ; Vs, Vineetha ; Punnoose, Varghese ; George, Josemon</creatorcontrib><description>Considering her age, raised ESR and prolonged APTT, SLE with anti-phospholipid antibody syndrome was strongly suspected and further evaluation revealed positive anti-nuclear antibody (ANA) by indirect immunofluorescence (IF)- 3+ nuclear homogenous pattern in 1:100 dilution, raised anti-double stranded DNA (Anti dsDNA)- 125 IU/ml (0-25 IU/ml), low C3- 47mg/dl (90-180mg/dl), low C4- 3.07mg/dl (10-40mg/dl) and positive lupus anticoagulant 1.94 (0-1.3). Magnetic resonance imaging (MRI) Brain was normal and Digital subtraction angiography (DSA) did not show any evidence of CNS vasculitis. [...]a final diagnosis of SLE with neuropsychiatric lupus in the form of left hemichorea and secondary antiphospholipid antibody syndrome was made. The American College of Rheumatology (ACR) nomenclature for neuropsychiatry syndromes in SLE includes 12 central nervous system syndromes and 7 peripheral nervous system syndromes.2 The classification of pathogenic mechanisms responsible for various neuropsychiatry syndromes into ischemic and neuroinflammatory may be an oversimplification of this clinically challenging entity. In prior case reports where chorea has been the presenting feature of SLE, the onset of other clinical features of SLE has varied from being present during the initial evaluation of chorea to a few weeks after the onset of chorea.9-13 The exact pathogenesis of chorea in SLE may be multifactorial involving 1) ischemia of small and large vessels in CNS mediated by anti-phospholipid antibodies and immune complexes, and 2) inflammatory neuronal injury secondary to complement activation, inflammatory cytokines, and increased permeability of blood-brain barrier causing autoantibodies to migrate to the intrathecal space.</description><identifier>ISSN: 2529-198X</identifier><identifier>EISSN: 2529-198X</identifier><identifier>DOI: 10.31138/mjr.180323.haf</identifier><identifier>PMID: 38736954</identifier><language>eng</language><publisher>Greece: PCO Convin S.A</publisher><subject>Antibodies ; Anticoagulants ; Case reports ; Dopamine ; Drug dosages ; Keywords ; Literature reviews ; Lupus ; Movement disorders ; Nervous system ; Open access publishing ; Patients ; Steroids</subject><ispartof>Mediterranean Journal of Rheumatology, 2024-03, Vol.35 (1), p.156-163</ispartof><rights>2024. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>313,314,780,784,792,27922,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38736954$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gangadharan, Harikrishnan</creatorcontrib><creatorcontrib>Peter, Rahul</creatorcontrib><creatorcontrib>Vs, Vineetha</creatorcontrib><creatorcontrib>Punnoose, Varghese</creatorcontrib><creatorcontrib>George, Josemon</creatorcontrib><title>Hemichorea as the First and Sole Manifestation in Lupus: Case-Based Review</title><title>Mediterranean Journal of Rheumatology</title><addtitle>Mediterr J Rheumatol</addtitle><description>Considering her age, raised ESR and prolonged APTT, SLE with anti-phospholipid antibody syndrome was strongly suspected and further evaluation revealed positive anti-nuclear antibody (ANA) by indirect immunofluorescence (IF)- 3+ nuclear homogenous pattern in 1:100 dilution, raised anti-double stranded DNA (Anti dsDNA)- 125 IU/ml (0-25 IU/ml), low C3- 47mg/dl (90-180mg/dl), low C4- 3.07mg/dl (10-40mg/dl) and positive lupus anticoagulant 1.94 (0-1.3). Magnetic resonance imaging (MRI) Brain was normal and Digital subtraction angiography (DSA) did not show any evidence of CNS vasculitis. [...]a final diagnosis of SLE with neuropsychiatric lupus in the form of left hemichorea and secondary antiphospholipid antibody syndrome was made. The American College of Rheumatology (ACR) nomenclature for neuropsychiatry syndromes in SLE includes 12 central nervous system syndromes and 7 peripheral nervous system syndromes.2 The classification of pathogenic mechanisms responsible for various neuropsychiatry syndromes into ischemic and neuroinflammatory may be an oversimplification of this clinically challenging entity. In prior case reports where chorea has been the presenting feature of SLE, the onset of other clinical features of SLE has varied from being present during the initial evaluation of chorea to a few weeks after the onset of chorea.9-13 The exact pathogenesis of chorea in SLE may be multifactorial involving 1) ischemia of small and large vessels in CNS mediated by anti-phospholipid antibodies and immune complexes, and 2) inflammatory neuronal injury secondary to complement activation, inflammatory cytokines, and increased permeability of blood-brain barrier causing autoantibodies to migrate to the intrathecal space.</description><subject>Antibodies</subject><subject>Anticoagulants</subject><subject>Case reports</subject><subject>Dopamine</subject><subject>Drug dosages</subject><subject>Keywords</subject><subject>Literature reviews</subject><subject>Lupus</subject><subject>Movement disorders</subject><subject>Nervous system</subject><subject>Open access publishing</subject><subject>Patients</subject><subject>Steroids</subject><issn>2529-198X</issn><issn>2529-198X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkE1LAzEQhoMottSevUnAi5dt87VN4k2LtUpF8AO8LdnNhG7p7tZkV_HfG20V8TIzDM-8DA9Cx5SMOKVcjauVH1FFOOOjpXF7qM9SphOq1cv-n7mHhiGsCCGMSqJVeoh6XEk-0anoo9s5VGWxbDwYbAJul4BnpQ8tNrXFj80a8J2pSwehNW3Z1Lis8aLbdOEcT02A5DIWix_grYT3I3TgzDrAcNcH6Hl29TSdJ4v765vpxSIpmKQs0aIQVusCOGVGECFUXBNmtZUObJ4WUhrnQCupU7Cam0JSkXMplMwn0kk-QGfb3I1vXrv4WVaVoYD12tTQdCHjJBWCx1wd0dN_6KrpfB2_y74MpppFS5Eab6nCNyF4cNnGl5XxHxkl35zKoulsazqLpuPFyS63yyuwv_yPV_4JV2J4Rg</recordid><startdate>20240301</startdate><enddate>20240301</enddate><creator>Gangadharan, Harikrishnan</creator><creator>Peter, Rahul</creator><creator>Vs, Vineetha</creator><creator>Punnoose, Varghese</creator><creator>George, Josemon</creator><general>PCO Convin S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20240301</creationdate><title>Hemichorea as the First and Sole Manifestation in Lupus: Case-Based Review</title><author>Gangadharan, Harikrishnan ; Peter, Rahul ; Vs, Vineetha ; Punnoose, Varghese ; George, Josemon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2712-94c4d99ce312a4044827102d9d7fedb5c77affe98795ed93ac714b37487b67f73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antibodies</topic><topic>Anticoagulants</topic><topic>Case reports</topic><topic>Dopamine</topic><topic>Drug dosages</topic><topic>Keywords</topic><topic>Literature reviews</topic><topic>Lupus</topic><topic>Movement disorders</topic><topic>Nervous system</topic><topic>Open access publishing</topic><topic>Patients</topic><topic>Steroids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gangadharan, Harikrishnan</creatorcontrib><creatorcontrib>Peter, Rahul</creatorcontrib><creatorcontrib>Vs, Vineetha</creatorcontrib><creatorcontrib>Punnoose, Varghese</creatorcontrib><creatorcontrib>George, Josemon</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Mediterranean Journal of Rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gangadharan, Harikrishnan</au><au>Peter, Rahul</au><au>Vs, Vineetha</au><au>Punnoose, Varghese</au><au>George, Josemon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hemichorea as the First and Sole Manifestation in Lupus: Case-Based Review</atitle><jtitle>Mediterranean Journal of Rheumatology</jtitle><addtitle>Mediterr J Rheumatol</addtitle><date>2024-03-01</date><risdate>2024</risdate><volume>35</volume><issue>1</issue><spage>156</spage><epage>163</epage><pages>156-163</pages><issn>2529-198X</issn><eissn>2529-198X</eissn><abstract>Considering her age, raised ESR and prolonged APTT, SLE with anti-phospholipid antibody syndrome was strongly suspected and further evaluation revealed positive anti-nuclear antibody (ANA) by indirect immunofluorescence (IF)- 3+ nuclear homogenous pattern in 1:100 dilution, raised anti-double stranded DNA (Anti dsDNA)- 125 IU/ml (0-25 IU/ml), low C3- 47mg/dl (90-180mg/dl), low C4- 3.07mg/dl (10-40mg/dl) and positive lupus anticoagulant 1.94 (0-1.3). Magnetic resonance imaging (MRI) Brain was normal and Digital subtraction angiography (DSA) did not show any evidence of CNS vasculitis. [...]a final diagnosis of SLE with neuropsychiatric lupus in the form of left hemichorea and secondary antiphospholipid antibody syndrome was made. The American College of Rheumatology (ACR) nomenclature for neuropsychiatry syndromes in SLE includes 12 central nervous system syndromes and 7 peripheral nervous system syndromes.2 The classification of pathogenic mechanisms responsible for various neuropsychiatry syndromes into ischemic and neuroinflammatory may be an oversimplification of this clinically challenging entity. In prior case reports where chorea has been the presenting feature of SLE, the onset of other clinical features of SLE has varied from being present during the initial evaluation of chorea to a few weeks after the onset of chorea.9-13 The exact pathogenesis of chorea in SLE may be multifactorial involving 1) ischemia of small and large vessels in CNS mediated by anti-phospholipid antibodies and immune complexes, and 2) inflammatory neuronal injury secondary to complement activation, inflammatory cytokines, and increased permeability of blood-brain barrier causing autoantibodies to migrate to the intrathecal space.</abstract><cop>Greece</cop><pub>PCO Convin S.A</pub><pmid>38736954</pmid><doi>10.31138/mjr.180323.haf</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2529-198X
ispartof Mediterranean Journal of Rheumatology, 2024-03, Vol.35 (1), p.156-163
issn 2529-198X
2529-198X
language eng
recordid cdi_proquest_miscellaneous_3054434489
source PubMed Central Open Access; PubMed Central
subjects Antibodies
Anticoagulants
Case reports
Dopamine
Drug dosages
Keywords
Literature reviews
Lupus
Movement disorders
Nervous system
Open access publishing
Patients
Steroids
title Hemichorea as the First and Sole Manifestation in Lupus: Case-Based Review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T17%3A06%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hemichorea%20as%20the%20First%20and%20Sole%20Manifestation%20in%20Lupus:%20Case-Based%20Review&rft.jtitle=Mediterranean%20Journal%20of%20Rheumatology&rft.au=Gangadharan,%20Harikrishnan&rft.date=2024-03-01&rft.volume=35&rft.issue=1&rft.spage=156&rft.epage=163&rft.pages=156-163&rft.issn=2529-198X&rft.eissn=2529-198X&rft_id=info:doi/10.31138/mjr.180323.haf&rft_dat=%3Cproquest_cross%3E3054434489%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3113592252&rft_id=info:pmid/38736954&rfr_iscdi=true